相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
Siham Ait Benichou et al.
GENE THERAPY (2022)
Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats
Ludovic Arandel et al.
NATURE BIOMEDICAL ENGINEERING (2022)
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis
Antoine Merien et al.
HUMAN MOLECULAR GENETICS (2022)
Mature Myotubes Generated From Human-Induced Pluripotent Stem Cells Without Forced Gene Expression
Kei Fujiwara et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein
Akihiro Kagita et al.
STEM CELL REPORTS (2021)
Characterization of hiPSC-Derived Muscle Progenitors Reveals Distinctive Markers for Myogenic Cell Purification Toward Cell Therapy
Minas Nalbandian et al.
STEM CELL REPORTS (2021)
Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells
Huaigeng Xu et al.
STAR PROTOCOLS (2021)
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
Tomoya Uchimura et al.
CELL REPORTS MEDICINE (2021)
Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy
Chaitali Misra et al.
DEVELOPMENTAL CELL (2020)
DM1 Phenotype Variability and Triplet Repeat Instability: Challenges in the Development of New Therapies
Stephanie Tome et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3′UTR RNA
Ramesh S. Yadava et al.
HUMAN MOLECULAR GENETICS (2020)
Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model
Mingming Zhao et al.
STEM CELL REPORTS (2020)
Three-dimensional imaging in myotonic dystrophy type 1 Linking molecular alterations with disease phenotype
Alfonsina Ballester-Lopez et al.
NEUROLOGY-GENETICS (2020)
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
Andrea Lopez-Martinez et al.
GENES (2020)
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels
Kaalak Reddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Transcriptome alterations in myotonic dystrophy skeletal muscle and heart
Eric T. Wang et al.
HUMAN MOLECULAR GENETICS (2019)
Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1
Yves Maury et al.
ISCIENCE (2019)
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes
Ellis Y. Kim et al.
JCI INSIGHT (2019)
Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery
Ricardo Mondragon-Gonzalez et al.
DISEASE MODELS & MECHANISMS (2018)
Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes
Paola Spitalieri et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
Sumitava Dastidar et al.
NUCLEIC ACIDS RESEARCH (2018)
Cells of Matter-In Vitro Models for Myotonic Dystrophy
Magdalena Matloka et al.
FRONTIERS IN NEUROLOGY (2018)
A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4
Mitsuru Sasaki-Honda et al.
HUMAN MOLECULAR GENETICS (2018)
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
Yanlin Wang et al.
MOLECULAR THERAPY (2018)
Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies
Guangbin Xia et al.
CURRENT STEM CELL REPORTS (2018)
Precise small-molecule recognition of a toxic CUG RNA repeat expansion
Suzanne G. Rzuczek et al.
NATURE CHEMICAL BIOLOGY (2017)
CRISPR/Cas9-Induced (CTG.GAG)n, Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
Ellen L. van Agtmaal et al.
MOLECULAR THERAPY (2017)
A human iPS cell myogenic differentiation system permitting high-throughput drug screening
Tomoya Uchimura et al.
STEM CELL RESEARCH (2017)
Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
Junko Ueki et al.
SCIENTIFIC REPORTS (2017)
Identification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotype
Mirjam Larsen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Functional analysis of SERCA1b, a highly expressed SERCA1 variant in myotonic dystrophy type 1 muscle
Yimeng Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Abnormal splicing switch of DMD's penultimate exon compromises muscle fibre maintenance in myotonic dystrophy
Frederique Rau et al.
NATURE COMMUNICATIONS (2015)
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Hongmei Lisa Li et al.
STEM CELL REPORTS (2015)
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Masato Nakagawa et al.
SCIENTIFIC REPORTS (2014)
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers
Valeria Guglielmi et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro
Akihito Tanaka et al.
PLOS ONE (2013)
An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells
Keisuke Okita et al.
STEM CELLS (2013)
Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice
Radbod Darabi et al.
CELL STEM CELL (2012)
Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex
Gerard M. J. Beaudoin et al.
NATURE PROTOCOLS (2012)
Down-Regulation of Myogenin Can Reverse Terminal Muscle Cell Differentiation
Nikolaos P. Mastroyiannopoulos et al.
PLOS ONE (2012)
Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus
Aline Huguet et al.
PLOS GENETICS (2012)
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
Charlotte Fugier et al.
NATURE MEDICINE (2011)
A more efficient method to generate integration-free human iPS cells
Keisuke Okita et al.
NATURE METHODS (2011)
Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2
Anna Vihola et al.
ACTA NEUROPATHOLOGICA (2010)
Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1
Misha Koshelev et al.
HUMAN MOLECULAR GENETICS (2010)
Muscleblind-Like Proteins Similarities and Differences in Normal and Myotonic Dystrophy Muscle
Ian Holt et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Thurman M. Wheeler et al.
SCIENCE (2009)
Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy
James P. Orengo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1
Shin-ichiro Hino et al.
HUMAN MOLECULAR GENETICS (2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation
N. Muge Kuyumcu-Martinez et al.
MOLECULAR CELL (2007)
SERCA pump isoforms: Their role in calcium transport and disease
Muthu Periasamy et al.
MUSCLE & NERVE (2007)
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy
Rahul N. Kanadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1
T Kimura et al.
HUMAN MOLECULAR GENETICS (2005)
MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1
W Dansithong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A muscleblind knockout model for myotonic dystrophy
RN Kanadia et al.
SCIENCE (2003)
Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat
A Mankodi et al.
SCIENCE (2000)
Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy
JW Miller et al.
EMBO JOURNAL (2000)
分享论文
